Form 4: Cheryl Xu Settles Restricted Stock Units in 60 Degrees Pharmaceuticals
SEC Form 4 Filing
Cheryl Xu, a director of 60 Degrees Pharmaceuticals, settled 2,000 restricted stock units for common stock on May 16, 2024.
Summary
- Cheryl Xu, a director of 60 Degrees Pharmaceuticals, settled 2,000 restricted stock units (RSUs) for shares of common stock on May 16, 2024.
- The transaction was reported on a Form 4 filing with the SEC.
- The price per share for the settlement was $0.223.
- Following the transaction, Ms. Xu directly owns 228,934 shares of common stock.
- The RSUs were initially granted on July 11, 2023, and subsequently modified to 4,000 RSUs, fully vesting as of December 31, 2023.
- Each RSU represents the right to receive one share of common stock at settlement.
Sentiment
Score: 5
Explanation: This is a routine transaction and filing, with no particularly positive or negative implications.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Key Dates
| Date | Description |
|---|---|
| 07/11/2023 | Initial grant of 8,000 restricted stock units to Ms. Xu. |
| 12/31/2023 | Restricted stock units fully vested. |
| 05/16/2024 | Settlement of 2,000 restricted stock units for common stock. |
| 05/21/2024 | Date of signature on the Form 4 filing. |
Keywords
Form 4, SEC, Beneficial Ownership, Restricted Stock Units, SXTP, 60 Degrees Pharmaceuticals, Cheryl Xu, Settlement
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.